Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M5,761Revenue $M1,345Net Margin (%)8.7Z-Score3.2
Enterprise Value $M6,225EPS $0.5Operating Margin %11.8F-Score7
P/E(ttm))62.7Cash Flow Per Share $1.7Pre-tax Margin (%)8.7Higher ROA y-yY
Price/Book2.610-y EBITDA Growth Rate %6.5Quick Ratio2.4Cash flow > EarningsY
Price/Sales4.55-y EBITDA Growth Rate %0.2Current Ratio2.7Lower Leverage y-yN
Price/Cash Flow10.9y-y EBITDA Growth Rate %-11.0ROA % (ttm)2.7Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)4.4Less Shares Outstanding y-yY
Payout Ratio %0Shares Outstanding M232ROI % (ttm)0.4Gross Margin Increase y-yY

Gurus Latest Trades with QGEN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
QGENRon Baron 2014-03-31 Sold Out $20.46 - $24.82
($22.48)
$ 24.839%Sold Out0
QGENRon Baron 2013-12-31 Reduce$20.63 - $24.65
($22.54)
$ 24.839%Reduce -49.00%10,200
QGENRon Baron 2013-06-30 Reduce$18.45 - $21.08
($19.52)
$ 24.8321%Reduce -45.95%20,000
QGENRon Baron 2012-03-31 Add$14.49 - $16.76
($14.43)
$ 24.8342%Add 26.98%40,000
QGENRon Baron 2010-12-31 Add$17.02 - $19.92
($18.77)
$ 24.8324%Add 44.23%37,500
QGENRon Baron 2010-09-30 Buy $17.66 - $20.62
($18.79)
$ 24.8324%New holding26,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

QGEN is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


QGEN: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about QGEN :

    Quarterly/Annual Reports about QGEN:

      News about QGEN:

      Articles On GuruFocus.com
      comment on QGEN May 14 2013 
      comment on QGEN May 10 2013 
      Biotech Gets Personal: Long on Qiagen (QGEN) & SPDR S&P Biotech (XBI) Feb 29 2012 
      Guru Stocks at 52-Week Lows: LMT, VIP, VMC, IRM, QGEN Oct 10 2010 
      Weekly Guru Bargains Highlights: QGEN, BXS, ATHR, LYV, TFSL Oct 09 2010 


      More From Other Websites
      QIAGEN N.V. to Report First Quarter 2015 Results Apr 16 2015
      Public tender offer on the shares of QIAGEN Marseille SA Apr 16 2015
      PUBLIC TENDER OFFER ON THE SHARES OF QIAGEN MARSEILLE SA Apr 16 2015
      QIAGEN Marseille announce that they have obtained the visa of the AMF on the simplified tender offer... Apr 15 2015
      QIAGEN announces proposal for re-election of all current Supervisory Board members at next Annual... Apr 02 2015
      QIAGEN Announces Proposal for Re-election of All Current Supervisory Board Members at Next Annual... Apr 02 2015
      Can Qiagen Continue to Grow in Molecular Diagnostics Space? - Analyst Blog Apr 01 2015
      Stocks to Cure What Ails on World TB Day - Analyst Blog Mar 24 2015
      QIAGEN partners with leading European service provider GATC Biotech to offer clients full access to... Mar 19 2015
      QIAGEN Partners With Leading European Service Provider GATC Biotech to Offer Clients Full Access to... Mar 19 2015
      QIAGEN Marseille announces that its shareholders in an extraordinary general meeting voted in favor... Mar 16 2015
      Tokai Pharmaceuticals Announces Expansion to Collaboration with Qiagen on the Development of an... Mar 16 2015
      QIAGEN Expands Leadership in Liquid Biopsies with New Circulating Tumor Cell Technology for... Mar 16 2015
      Coverage initiated on Qiagen by UBS Mar 10 2015
      QIAGEN NV Financials Mar 06 2015
      QIAGEN collaborates with Allele Frequency Community to advance translational medicine and clinical... Feb 24 2015
      QIAGEN Collaborates With Allele Frequency Community to Advance Translational Medicine and Clinical... Feb 24 2015
      QIAGEN Marseille accepts the HalioDx offer for acquisition of its assets except IP Feb 18 2015
      Largest-Ever Pivotal Study in China Supports QIAGEN's QuantiFERON®-TB Gold Over Tuberculin Skin... Feb 11 2015
      Qiagen (QGEN) Disappoints with Q4 Earnings, Revenue Miss - Analyst Blog Jan 30 2015

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      FEEDBACK